SITAGLIPTINE BEKER ®

Sitagliptin BEKER® is a DPP-4 inhibitor (dipeptidylpeptidase 4 inhibitor) .It is indicated for the treatment of non-insulin-dependent diabetes as an adjunct to diet and exercise, either as monotherapy or in combination with other therapies. antidiabetic drugs.

Additional information

DCI

SITAGLIPTINE

Dosage

50 mg

Trade name

SITAGLIPTINE BEKER ®

Name of the originator

Januvia

Presentation

30 tablets

Specialty

Métabolisme – ADO

See also